Abstract
People with epilepsy often report the negative impact of their condition on many aspects of quality of life (QOL). While surgical intervention is aimed at reducing or stopping seizures, there is an implicit assumption among both patients and physicians that successful surgery will result in beneficial changes in quality-of-life measures (see Chap. 16). This chapter reviews the quality-of-life (QOL) outcome literature in epilepsy surgery. The majority of studies in this field have utilized follow-up intervals of no more than 1–2 years. The literature is diverse and a wide range of surgical procedures, QOL measures, sample sizes, ages at onset, follow-up intervals, and controlled versus noncontrolled study designs have been reported. Improvements in QOL do not automatically accompany seizure freedom, in the short term at least. Psychiatric comorbidities, employment status, ability to drive, and antiepileptic drug (AED) cessation appear to be better predictors of health-related quality-of-life measures than seizure freedom alone. Improvements in QOL measures may be more common following right versus left temporal lobe resections. There is a complex relationship between measures of cognitive decline and seizure freedom following surgery with respect to their impact on QOL measures. At present, little is known about the impact of surgery at different stages in adulthood. It is likely that QOL changes are different for those who have surgery in the 20s compared to those in middle age or later. Future research in this area should incorporate standardized measures of seizure outcome and QOL measures with normative data. Studies must also employ valid measures that capture meaningful change in QOL from the patient’s perspective at different time points after epilepsy surgery. It is likely that meaningful changes in QOL will take many years to develop after surgery, particularly for those patients who have lived most of their lives with epilepsy. Outcome studies with follow-up periods of 12–24 months are likely to underestimate the benefits of seizure freedom conferred by surgery. Only studies with longer-term follow-ups are able to accurately measure the impact in this domain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- ESI-55:
-
Epilepsy Surgery Inventory-55
- ILAE:
-
International League Against Epilepsy
- IQ:
-
Intelligence quotient
- QOL:
-
Quality of life
- QOLIE:
-
Quality of Life in Epilepsy
- SF-36:
-
Short Form Health Survey-36
- SHE:
-
Subjective Handicap of Epilepsy
- VNS:
-
Vagus nerve stimulator
- US:
-
United States
References
Wiebe S, Blume WT, Girvin JP, Eliasziw M, Effectiveness and Efficiency of Surgery for Temporal Lobe Epilepsy Study Group. A randomized, controlled trial of surgery for temporal-lobe epilepsy. N Engl J Med. 2001;345:311–8.
Engel Jr J, Wiebe S, French J, Sperling M, Williamson P, Spencer D, Gumnit R, Zahn C, Westbrook E, Enos B, Quality Standards Subcommittee of the American Academy of Neurology, American Epilepsy Society, American Association of Neurological Surgeons. Practice parameter: temporal lobe and localized neocortical resections for epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology, in association with the American Epilepsy Society and the American Association of Neurological Surgeons. Neurology. 2003;60:538–47.
Seiam AH, Dhaliwal H, Wiebe S. Determinants of quality of life after epilepsy surgery: systematic review and evidence summary. Epilepsy Behav. 2011;21:441–5.
Taylor RS, Sander JW, Taylor RJ, Baker GA. Predictors of health-related quality of life and costs in adults with epilepsy: a systematic review. Epilepsia. 2011;52:2168–80.
Engel Jr J, McDermott MP, Wiebe S, Langfitt JT, Stern JM, Dewar S, Sperling MR, Gardiner I, Erba G, Fried I, Jacobs M, Vinters HV, Mintzer S, Kieburtz K, Early Randomized Surgical Epilepsy Trial (ERSET) Study Group. Early surgical therapy for drug-resistant temporal lobe epilepsy: a randomized trial. JAMA. 2012;307:922–30.
Fiest KM, Sajobi TT, Wiebe S. Epilepsy surgery and meaningful improvements in quality of life: results from a randomized controlled trial. Epilepsia. 2014;55:886–92.
Vickrey BG, Hays RD, Rausch R, Engel Jr J, Visscher BR, Ary CM, Rogers WH, Brook RH. Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery. Lancet. 1995;346:1445–9.
Kellett MW, Smith DF, Baker GA, Chadwick DW. Quality of life after epilepsy surgery. J Neurol Neurosurg Psychiatry. 1997;63:52–8.
Mikati MA, Comair YG, Rahi A. Normalization of quality of life three years after temporal lobectomy: a controlled study. Epilepsia. 2006;47:928–33.
Taft C, Sager Magnusson E, Ekstedt G, Malmgren K. Health-related quality of life, mood, and patient satisfaction after epilepsy surgery in Sweden–a prospective controlled observational study. Epilepsia. 2014;55:878–85.
McGlone J, Valdivia I, Penner M, Williams J, Sadler RM, Clarke DB. Quality of life and memory after vagus nerve stimulator implantation for epilepsy. Can J Neurol Sci (Le Journal Canadien Des Sciences Neurologiques). 2008;35:287–96.
Kim YH, Kim HI. Assessing quality of life for the measurement of outcome after epilepsy surgery. Psychiatry Clin Neurosci. 1995;49:S304–5.
Kanchanatawan B, Kasalak R. Quality of life in Thai intractable epileptic patients with and without surgery. J Med Assoc Thai. 2012;95:1232–8.
Stavem K, Bjørnaes H, Langmoen IA. Long-term seizures and quality of life after epilepsy surgery compared with matched controls. Neurosurgery. 2008;62:326–34.
Bien CG, Schulze-Bonhage A, Soeder BM, Schramm J, Elger CE, Tiemeier H. Assessment of the long-term effects of epilepsy surgery with three different reference groups. Epilepsia. 2006;47:1865–9.
Gilliam F, Kuzniecky R, Meador K, Martin R, Sawrie S, Viikinsalo M, Morawetz R, Faught E. Patient-oriented outcome assessment after temporal lobectomy for refractory epilepsy. Neurology. 1999;53:687–94.
Choi-Kwon S, Chung CK, Lee SK, Choi J, Han K, Lee EH. Quality of life after epilepsy surgery in Korea. J Clin Neurol. 2008;4:116–22.
Engel Jr J. Outcome with respect to epileptic seizures. In: Engel Jr J, editor. Surgical treatment of the epilepsies. New York: Raven Press; 1987. p. 553–71.
Wieser HG, Blume WT, Fish D, Goldensohn E, Hufnagel A, King D, Sperling MR, Luders H, Pedley TA, Commission on Neurosurgery of the International League Against Epilepsy (ILAE). ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia. 2001;42:282–6.
Markand ON, Salanova V, Whelihan E, Emsley CL. Health-related quality of life outcome in medically refractory epilepsy treated with anterior temporal lobectomy. Epilepsia. 2000;41:749–59.
Vickrey B, Perrine K, Hays R, Hermann B, Cramer J, Gordon J, Meador K, Devinsky O. Scoring manual and patient inventory for the quality of life in epilepsy inventory-89 (QOLIE-89). Santa Monica: RAND; 1993.
Cramer JA, Perrine K, Devinsky O, Bryant-Comstock L, Meador K, Hermann B. Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory. Epilepsia. 1998;39:81–8.
Cramer JA, Perrine K, Devinsky O, Meador K. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia. 1996;37:577–82.
Vickrey BG, Hays RD, Graber J, Rausch R, Engel Jr J, Brook RH. A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care. 1992;30:299–319.
Ware J, Sherbourne C. The SF-36 health status survey: I. Conceptual frame-work and item selection. Med Care. 1992;30:473–83.
Skevington SM, Lotfy M, O’Connell KA, Group W. The World Health Organization’s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13:299–310.
Baker G, Jacoby A, Smith D, Dewey M, Johnson A, Chadwick D. Quality of life in epilepsy: the Liverpool initiative. In: Trimble M, Dobson W, editors. Epilepsy and quality of life. New York: Raven Press; 1994. p. 135–50.
McLachlan RS, Rose KJ, Derry PA, Bonnar C, Blume WT, Girvin JP. Health-related quality of life and seizure control in temporal lobe epilepsy. Ann Neurol. 1997;41:482–9.
Aydemir N, Ozkara C, Canbeyli R, Tekcan A. Changes in quality of life and self-perspective related to surgery in patients with temporal lobe epilepsy. Epilepsy Behav. 2004;5:735–42.
Helmstaedter C, Kurthen M, Lux S, Reuber M, Elger CE. Chronic epilepsy and cognition: a longitudinal study in temporal lobe epilepsy. Ann Neurol. 2003;54:425–32.
Malmgren K, Sullivan M, Ekstedt G, Kullberg G, Kumlien E. Health-related quality of life after epilepsy surgery: a Swedish multicenter study. Epilepsia. 1997;38:830–8.
Selai CE, Trimble MR, Rossor MN, Harvey RJ. Effectiveness of rivastigmine in Alzheimer’s disease. Patients’ view on quality of life should be assessed. BMJ. 1999;319:641–2.
Reid K, Herbert A, Baker GA. Epilepsy surgery: patient-perceived long-term costs and benefits. Epilepsy Behav. 2004;5:81–7.
Buschmann F, Wagner K, Metternich B, Biethahn S, Zentner J, Schulze-Bonhage A. The impact of extratemporal epilepsy surgery on quality of life. Epilepsy Behav. 2009;15:166–9.
Elsharkawy AE, May T, Thorbecke R, Ebner A. Predictors of quality of life after resective extratemporal epilepsy surgery in adults in long-term follow-up. Seizure. 2009;18:498–503.
Mohammed HS, Kaufman CB, Limbrick DD, Steger-May K, Grubb Jr RL, Rothman SM, Weisenberg JL, Munro R, Smyth MD. Impact of epilepsy surgery on seizure control and quality of life: a 26-year follow-up study. Epilepsia. 2012;53:712–20.
Schramm J, Delev D, Wagner J, Elger CE, von Lehe M. Seizure outcome, functional outcome, and quality of life after hemispherectomy in adults. Acta Neurochir (Wien). 2012;154:1603–12.
Cankurtaran ES, Ulug B, Saygi S, Tiryaki A, Akalan N. Psychiatric morbidity, quality of life, and disability in mesial temporal lobe epilepsy patients before and after anterior temporal lobectomy. Epilepsy Behav. 2005;7:116–22.
Lowe AJ, David E, Kilpatrick CJ, Matkovic Z, Cook MJ, Kaye A, O'Brien TJ. Epilepsy surgery for pathologically proven hippocampal sclerosis provides long-term seizure control and improved quality of life. Epilepsia. 2004;45:237–42.
Ahmad FU, Tripathi M, Padma MV, Gaikwad S, Gupta A, Bal CS, Sarkar C, Gupta S, Wadhawan AN, Sharma BS, Chandra PS. Health-related quality of life using QOLIE-31: before and after epilepsy surgery a prospective study at a tertiary care center. Neurol India. 2007;55:343–8.
Cunha I, Oliveira J. Quality of life after surgery for temporal lobe epilepsy: a 5-year follow-up. Epilepsy Behav. 2010;17:506–10.
Maganti R, Rutecki P, Bell B, Woodard A, Jones JC, Ramirez L, Iskandar B. Epilepsy surgery outcome among US veterans. Epilepsy Behav. 2003;4:723–8.
Tanriverdi T, Poulin N, Olivier A. Life 12 years after temporal lobe epilepsy surgery: a long-term, prospective clinical study. Seizure. 2008;17:339–49.
Rose KJ, Derry PA, Wiebe S, McLachian RS. Determinants of health-related quality of life after temporal lobe epilepsy surgery. Qual Life Res. 1996;5:395–402.
O'Donoghue MF, Duncan JS, Sander JW. The subjective handicap of epilepsy. A new approach to measuring treatment outcome. Brain. 1998;121(Pt 2):317–43.
Langfitt JT, Westerveld M, Hamberger MJ, Walczak TS, Cicchetti DV, Berg AT, Vickrey BG, Barr WB, Sperling MR, Masur D, Spencer SS. Worsening of quality of life after epilepsy surgery: effect of seizures and memory decline. Neurology. 2007;68:1988–94.
Baker GA, Smith DF, Dewey M, Jacoby A, Chadwick DW. The initial development of a health-related quality of life model as an outcome measure in epilepsy. Epilepsy Res. 1993;16:65–81.
von Lehe M, Lutz M, Kral T, Schramm J, Elger CE, Clusmann H. Correlation of health-related quality of life after surgery for mesial temporal lobe epilepsy with two seizure outcome scales. Epilepsy Behav. 2006;9:73–82.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Appendices
Appendix 12.1. Summary of Study Characteristics and Results from Controlled Studies of Quality of Life after Epilepsy Surgery in adults
Author | Surgical procedure | Sample size | Age at onset | Age at surgery | Study age | Outcome measures | Seizure outcome | Summary of results | Follow-up interval |
---|---|---|---|---|---|---|---|---|---|
1. Kim et al. [12] | Not specified | 19 surgery 21 no surgery 20 control | Not reported | Not reported | Surgery: 26.8 Control: 26.5 | Korean version of QOLIE-89 | Not reported | Individuals in surgery and no-surgery groups reported lower scores overall as compared to controls. The surgery group had improved postop QOL scores. | Pre-surgery and >3 mo. postop evaluation |
2. Vickrey et al. [7] | Anterior temporal lobectomy (n = 175) Extratemporal lobectomy (n = 22) | 202 surgery 46 no surgery | Surgery: 11.9 years No surgery: 12 years | Not reported | Surgery: 27 years No surgery: 26 years | ESI-55 (at follow-up only) Employment KAS AEDs Seizure outcome | Surgery: 60 % SF (no seizures, auras or 1 seizure) No surgery: 11 % SF | The surgery group scored significantly higher on 5 of 11 scales (seizure health perception, social function, pain, role limitations caused by physical problems and role limitations caused by emotional problems). | Pre-surgery, 5.8 years for surgery 5.7 years for no surgery |
3. Kellet et al. [8] | 48 % Anterior temporal lobectomy 25 % Amygdalohippocampectomy 18 % Temporal lesionectomy 9 % Extratemporal resection | 94 surgery 36 no surgery | Surgery: 11.7 years No surgery: 12.4 years | Not reported | Surgery: 33.1 years No surgery: 33.6 years | Overall QOL Overall health Impact of epilepsy AEDs Seizure frequency Surgery satisfaction Stigma Mastery Anxiety Self-esteem Depression Affect balance Employment or education HRQOL model (Baker et al. [47]) | Surgery: 47.9 % in the past year. (auras counted as seizures). | QOL outcomes were significantly better for SF group post-surgery than those with continuous seizures and the no-surgery group. QOL improved for participants with less frequent seizures, but to a lesser degree. | 1986–1994 (years included in follow-up) No interval given. |
4. McLachlan et al. [28] | Temporal lobectomy | 51 surgery 21 no surgery | Surgery: 12.1 years No surgery: 17 years | Not reported | Surgery: 31.9 years No surgery: 34.2 years (baseline) | ESI-55 | Surgery: 88 % >90 % reduction or SF Nonsurgery: 8 % >90 % reduction or SF (2-yr follow-up) | SF group and participants with at least 90 % seizure reduction improved in QOL post-surgery. This improvement was most evident at 2-yr follow-up. QOL deteriorated with < 90 % seizure reduction. | Pre-surgery, 6, 12, and 24 months |
5. Gilliam et al. [16] | Anterior temporal lobectomy | 125 surgery 71 waitlist control | Surgery: 12.3 years Waitlist: 14 years | Surgery: 31 years Wait-list: 33 years | Not reported | ESI-55 POMS Driving Employment/school AEDs Seizure frequency Adverse events profile | Surgery: 65 % SF (no seizures or only auras) | Surgery group had better QOL scores in 8 or 11 scales. SF status and IQ not associated with better QOL. Mood status, employment, driving and AED cessation were associated with better QOL. | 12 and 24 months |
6. Markand et al. [20] | Anterior temporal lobectomy | 53 surgery 37 no surgery | Surgery: 12.3 years No surgery: 13.4 years | Not reported | Surgery: 31 years No surgery: 36.9 year (baseline) | QOLIE-89 | Surgery: 73.6 % SF No surgery: 0 % SF (Engel classification) | Overall QOL score and 10 of 17 scale scores improved in surgery group and was related to SF status | Pre-surgery, 1 and 2 years |
7. Helmstaedter et al. [30] | Temporal lobectomy | 147 surgery 120 no surgery | Surgery: 12 years No surgery: 17 years | Not reported | Surgery: 31 years No surgery: 35 years | QOLIE-10 VLMT DCS-R Employment or school BDI | Surgery: 63 % SF No surgery: 12 % SF | Seizure free improvement of non-memory functions in T1-T2 and improvement of memory in T2-T3 Seizure free less impaired QOLIE-10 scores and less depression | Pre-surgery, 1 year and 2–10 years |
8. Aydemir et al. [29] | Temporal lobectomy | 21 surgery 20 pre-surgery | Surgery: 8 years Pre-surgery: 6.3 years | Not reported | Surgery: 27 years Pre-surgery: 24.8 years | SF-36 BDI STAI Stigma Perceived impact of epilepsy Opinions on epilepsy and surgery | Surgery: 47.6 % SF | QOL of post-surgery was better than scores before surgery | 6 months to 4 years Average 27 months |
9. Bien et al. [15] | Temporal lobectomy | 131 surgery 105 waitlist control 99 presurgical candidates 49 no surgery | Not reported | Not reported | Surgery: 31.1 years Waitlist: 35.8 years Presurgical: 31.9 years No surgery: 36.6 years | ESI-55 Seizure questionnaire AEDs | Surgery: 52 % SF Waitlist: 5 % SF Presurgical: 14 % SF No surgery: 24 % SF | QOL scores of SF higher than those who were not SF | Minimum 1 year |
10. Mikati et al. [9] | 75 % Temporal lobectomy 25 % Extratemporal resections | 20 surgery 17 no surgery 20 controls | Surgery: 9.3 years No surgery: 14.82 years | Not reported | Surgery: 30.5 years No surgery: 31.5 years Control: 29.2 years | ESI-55 | Surgery: 85 % SF No surgery: 35 % SF (Engel classification) | QOL was significantly better in surgery group than in nonsurgery group and reached similar levels to healthy controls at 3-year follow-up | 3 years |
11. Stavem et al. [14] | Resective surgery for focal epilepsy | 70 surgery 70 matched controls | Surgery: 9.4 years No surgery: 9.6 years | Surgery: 24 years | Surgery: 37 years No surgery: 37 years | QOLIE-89 | Surgery: 48 % SF No surgery: 19 % SF | Surgery patients had higher HRQOL scores than nonsurgery patients | Average 15 years |
12. McGlone et al. [11] | Anterior temporal lobectomy (n = 8) Amygdalohippocampectomy (n = 1) Hemispherectomy (n = 1) | 16 VNS, 10 surgery 9 no surgery | Not reported | Not reported | VNS: 35 years Surgery: 36 years No surgery: 37 years | QOLIE-89 GDS WMS, MOQ | Not reported | QOL improved more in surgery group than in VNS or medically managed group | Pre-surgery and 1 year |
13. Choi-Kwon et al. [17] | Anterior temporal lobectomy (n = 22) Other (n = 10) | 32 surgery 32 no surgery | Not reported | Not reported | Surgery: 30.6 years No surgery: 31.4 years | Korean ESI-55 Seizure outcome AEDs Seizure stigma Korean version of HADS | Surgery: 84 % SF No surgery: 45 % SF (2-yr follow-up) | QOL improved in surgery group but not in nonsurgery group. At 6 months, SF was an important factor in QOL, while at 2 years, AEDs and depression were important | Pre-surgery, 6 months and 2 years |
14. Engle et al. [5] | Temporal lobectomy | 15 surgery 23 no surgery | Not reported | Not reported | Surgery: 37.5 years No surgery: 30.9 years (baseline) | QOLIE-89 QOLIE AD-48 Seizure outcome | Surgery: 73 % SF No surgery: 0 % SF | QOL scores were higher in the surgery group than the no-surgery group, but this difference was not significant | Pre-surgery, and every 3 months for 2 years |
15. Kanchanatawan [13] | Not specified | 60 surgery 60 no surgery | Not reported | Not reported | Surgery: 36.1 years No surgery: 29.3 years | Thai version of WHOQOL-BREF-26 Thai version of HDRS | Surgery: 66.7 % SF No surgery: 5 % SF | Surgery group had better QOL scores than nonsurgery group and had similar QOL scores compared to the general Thai population | Minimum 1 year |
16. Fiest et al. [6] | Temporal lobectomy | 40 surgery 40 no surgery | Surgery: 14.3 years No surgery: 16.2 years | Not reported | Surgery: 35.5 years No surgery: 34.4 years (baseline) | QOLIE-89 QOLIE-31 SF-36 HUI-III GHQ | Surgery: 38 % SF No surgery: 3 % SF | More surgery group had meaningful improvement in QOL than nonsurgery group. No surgery group had worsening of QOL at follow-ups | Pre-surgery, 6 and 12 months |
17. Taft et al. [10] | Temporal lobectomy (n = 80) Frontal lobectomy (n = 12) Parietal lobectomy (n = 1) Multilobe resection (n = 1) Hemispherectomy (n = 1) Multiple subpial transection (n = 1) | 96 surgery 45 no surgery | Not reported | Not reported | Surgery: Median 33 years No surgery: Median 33 years (baseline) | SF-36 Seizure freedom HADS Surgery satisfaction | Surgery: 55 % SF No surgery: 11 % SF (ILAE classification) | QOL scores of SF surgery group reached norm at follow-up except in social functioning No change in not SF groups | Pre-surgery and average 2 years follow-up |
Appendix 12.2. Summary of Study Characteristics and Results from Noncontrolled Studies of Quality of Life after Epilepsy Surgery in adults
Authors | Surgical procedure | Sample size | Age at onset | Age at surgery | Study age | Outcomes measures | Seizure outcome | Summary of results | Follow-up interval |
---|---|---|---|---|---|---|---|---|---|
1. Rose et al. [44] | Temporal lobectomy | 47 | 11.5 years | Not reported | 32 years (baseline) | ESI-55 Seizure outcome | 44 % SF (Vickrey et al. [7]) | Preoperative QOL more predictive of postoperative QOL than seizure outcome Greatest improvement seen in low or medium preoperative QOL scores High preoperative QOL scores did not see the same improvement, but scores remained high postoperatively | Pre-surgery, 1 or 2 years |
2. Malmgren et al. [31] | Temporal lobectomy (n = 73) Extratemporal lobectomy (n = 25) Other (n = 5) | 103 | 10.9 years | 27.9 years | 32.1 years (follow-up) | SF-36 HADS Seizure outcome Single item QOL scale (Aaronson et al., 1992) | 46 % SF (no seizures or only auras) | QOL is scored as a continuum in relation to seizure frequency; scores improve with decreased seizure frequency Seizure severity follows the same pattern | Pre-surgery, Average 4 years |
3. Selai et al. [32] | Temporal lobectomy (n = 20) Extratemporal lobectomy (n = 5) | 22 | 9.6 years | Not reported | 32.8 years | QOLAS ESI-55 EQ-5D | 100 % > 75 % reduction in seizures | QOL scores improved at 1 year follow-up | Pre-surgery, Average 1 year |
4. Maganti et al. [42] | Anterior temporal lobectomy | 27 | 25 years | 43.8 years | Not reported | QOLIE-31 Seizure outcome Employment | 67 % SF (Engle classification) | Postop seizure outcome for US veterans was consistent with outcome seen in general population Better post-surgery seizure outcomes had higher QOL scores Employment outcome was better with good seizure outcome | 2–13 years |
5. Reid et al. [33] | Anterior temporal lobectomy (n = 32) Amydalohippocampectomy (n = 16) Temporal lesionectomy (n = 13) Extratemporal lesionectomy (n = 3) Other (n = 3) | 67 | 11.2 years | Median 29 years | 41.4 years | Overall QOL Overall health Impact of epilepsy AEDs Seizure frequency Surgery satisfaction Stigma Mastery Anxiety Self-esteem Depression Affect balance Employment or education HRQOL model (Baker et al. [47]) | 44.8 % SF | Significantly more SF participants were employed and had a driver’s license after surgery SF reported better QOL, psychological and psychosocial outcomes than those with continuous seizures | Average 10.3 years |
6. Lowe et al. [39] | Temporal lobectomy | 48 | Not reported | 42.7 years | Not reported | QOLIE-89 Seizure outcome AEDs | 80 % SF (Engel classification) | Better seizure outcome had better QOL scores | Average 5.8 years |
7. Cankurtaran et al. [38] | Anterior temporal lobectomy | 22 | 10.5 years | 30 years | Not reported | WHOQOL-BREF WHO-DAS-II SCID-I BPRS HDRS HARS | Not reported | Improvement seen in social domains of WHO-DAS-II postoperatively All participants were more satisfied with health post-surgery No significant difference found between pre- and postop general evaluation of QOL in WHOQOL-BREF | Pre-surgery, 3 and 6 months |
8. Ahmad et al. [40] | Anterior temporal lobectomy w/subpial amygdalohippocampectomy and Lesionectomy (Numbers for each group not specified) | 36 | Not reported | Not reported | ~25 years | QOLIE-31 Seizure outcome | 77 % SF (Engel classification) | Improvement shown in all QOL domains in SF group and some domains (seizure worry, overall QOL, emotional wellbeing and social functioning) in not SF group Stronger score gains seen in SF | Pre-surgery and 6 months |
9. Langfitt et al. [46] | Temporal lobectomy | 138 | 14.9 years | Not reported | 39.5 years (baseline) | QOLIE-89 Seizure control CVLT (verbal memory) | 56 % SF at 2 and 5 year 26 % SF at 2 or 5 year | Improved QOL in SF group despite memory decline QOL declined when not SF was accompanied by memory decline and remained stable when there was no memory decline No relationship between cognition and QOL | Pre-surgery, Average 2 and 5 years |
10. Tanriverdi et al. [43] | Selective Amygdalohippocampectomy (n = 33) Cortico-amygdalahippocampectomy (n = 20) Lesionectomy Temporal lobe (n = 10) | 63 | 7.1 years | 33.8 years | 34.4 years | QOLIE-10 Seizure outcome AEDs Employment | 70.8 % SF (Engel classification) | Improvement in QOL was seen regardless of seizure outcome after surgery SF had high ratings of QOL than those who continued to have seizures Better QOL when AEDs were reduced or discontinued | Pre-surgery, 6 months, 2 years, and 12 years |
11. Buschmann et al. [34] | Extratemporal resection | 21 | Not reported | Not reported | 32.3 years | SHE Seizure outcome BDI Neuropsychological evaluation | 52.4 % SF (Engel classification) | QOL improved after surgery regardless of seizure outcome No relationship between QOL and neuropsychological test performance | Pre-surgery and 1 year |
12. Cunha and Oliveira [41] | Temporal lobectomy | 32 | Not reported | Not reported | 41.4 years | QOLIE-31 Seizure outcome SCL-90 | 62.5 % SF (Engel classification) | QOL improved after surgery regardless of seizure outcome. More significant gains seen in SF group than those who continued to have seizures. | Pre-surgery, 1, 3 and 6 months and annually for 1–5 years |
13. Elsharkawy et al. [35] | Extratemporal resection | 87 | 13.9 years | 30.1 years | 37.3 years (follow-up). | QOLIE-31 Seizure outcome AEDs Employment Driving Psychiatric treatment Medical comorbidities | 51.7 % SF | Seizure freedom was the most powerful predictor of QOL; SF was associated with higher QOL ratings Medical comorbidities were the second most important predictor of QOL | Average 7.2 years |
14. Mohammed et al. [36] | Temporal resection (n = 60) Extratemporal resection (n = 24) Hemispherectomy (n = 8) Callosotomy (n = 6) More than 1 surgery type (n = 71) | 117 | 9.1 years | 21 years | Not reported | QOLIE-31 Seizure outcome | 48 % SF (Engel classification) | The majority reported improvement in quality of life after surgery Postoperative SF was associated with better QOL | Average 26 years |
15. Schramm et al. [37] | Hemispherectomy | 27 | Median 5 years | Median 30 years | Not reported | German version based on ESI-55; 17 item version (Von Lehe et al. [48]) German -Functional status Seizure outcome Morbidity | 81 % SF (ILAE classification) | QOL scores improved after surgery. | Median 9.6 years Minimum follow-up 1 year |
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Jones, J.E., Hanson, M. (2015). Quality-of-Life Outcomes in Adults Following Epilepsy Surgery. In: Malmgren, K., Baxendale, S., Cross, J. (eds) Long-Term Outcomes of Epilepsy Surgery in Adults and Children. Springer, Cham. https://doi.org/10.1007/978-3-319-17783-0_12
Download citation
DOI: https://doi.org/10.1007/978-3-319-17783-0_12
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-17782-3
Online ISBN: 978-3-319-17783-0
eBook Packages: MedicineMedicine (R0)